Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast‐enhanced ultrasound: An updated meta‐analysis

Deng, Helen; Jianming, Lei; Jin, Lixian; Shi, Hongwei

doi:10.1111/1759-7714.14139

Cited by 10 publications

(16 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NAC refers to systemic cytotoxic drug therapy before surgery or radiotherapy for malignant tumors [ 20 ]. Studies by some scholars have shown that there is no considerable difference in the survival rate between NAC and postoperative chemotherapy for the breast cancer patients [ 21 ].…”

Section: Discussionmentioning

confidence: 99%

Diagnostic Significance of 3D Automated Breast Volume Scanner in a Combination with Contrast-Enhanced Ultrasound for Breast Cancer

Yuan¹,

Song²,

Tian³

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

The incidence of cancer is increasing today, particularly lung and chest cancer. Employing novel methods to detect cancer in its earliest stages and discover painless, noninvasive treatments are urgently needed. The goal of the proposed study is to investigate the value of automated breast volume scanning (ABUS) in conjunction with contrast-enhanced ultrasonography (CEUS) in properly diagnosing breast cancer in its early stages and the effectiveness of neoadjuvant chemotherapy (NAC) in treating the disease. For the research study, information on 98 patients who had NAC and surgery in the breast surgery department of the Shaanxi Provincial Cancer Hospital has been gathered. All patients have received four cycles of NAC and underwent conventional ultrasound (HUSS), CEUS, ABUS, and pathological examination. At the same time, receiver operating characteristic (ROC) curve analysis, single factor, multiple linear regression, and other methods have also been used to analyze the diagnostic efficacy of breast cancer and NAC efficacy evaluation results. The study of this paper is totally based on the data collected from Shaanxi Provincial Cancer Hospital. The statistical and computational analyses are performed on the data collected for drawing inferences. When the findings are compared to the results of the pathological examination, HUSS has demonstrated a significant distinction between benign and malignant diagnoses with a statistical value of P < 0.05 .ABUS combined with CEUS has shown no considerable differences in correlation study. Except for negative likelihood ratio, the diagnostic performance indexes of CEUS+ ABUS are substantially higher than HHUS with P < 0.05 . ROC curve analysis is also performed which shows that CEUS and ABUS combination has higher precision in the analysis of breast cancer. ABUS pooled with CEUS shows great application value in the judgment of breast cancer as per the results obtained from the statistical analysis on data of 98 patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Diagnostic Significance of 3D Automated Breast Volume Scanner in a Combination with Contrast-Enhanced Ultrasound for Breast Cancer

Yuan¹,

Song²,

Tian³

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…The sentinel lymph node (LS) technique is performed in those patients with biopsy-proven malignant breast disease that meet certain criteria, without which the examination would not be useful. Most of them are referable to the TNM classification, which is an international system of classification of malignant tumors, from which the stage of the disease can be derived [11,12].…”

Section: Discussionmentioning

confidence: 99%

Sentinel Lymph Node in Breast Cancer: An Innovative Techniques

Izzo¹,

Izzo²,

Sibio³

et al. 2022

Preprint

View full text Add to dashboard Cite

(1) Background: Sentinel lymph node biopsy assumes importance in the search for metastases, especially in patients with malignant breast disease. Our study approaches the new techniques to prevent complications such as possible postoperative seroma formation, pain or hypoesthesia of the axillary cord and medial arm surface, as well as motor deficits in a preventive manner to avoid disabling outcomes and presents initial data from its experience with the sentinel lymph node biopsy technique. (2) Methods: There are mainly two radioactive tracer detection techniques and a new technique using a radiotracer called Sentimag-magtrace. The positive lymph node is located and removed to perform histologic analysis. In our study, we evaluate 100 patients who underwent breast cancer surgery (3) Results: our experience allowed us to calculate the identification rate with the different methods of sentinel lymph nodes by radioactive tracer 88.9 % vs magnetic tracer technology (Sendimag) 89.5%. (4) Conclusions Thus, this technique avoids radiation exposure for both patients and health care providers, as well as reducing costs and time.

show abstract

“…Therefore, if the SLN is deemed to be free of metastatic cancer cells the remaining regional LNs are also considered to be negative for metastatic disease, conversely if the SLN contains infiltrating metastatic cells then all the remaining LNs in that lymphatic drainage pathway are considered to be positive for metastatic disease [1,3,4]. The determination of the presence and extent of regional LN involvement is used to guide treatment selection and remains the most powerful predictor of recurrence and survival [6][7][8][9][10][11]. At the time of the cancer diagnosis the regional lymphatic chain and LNs are evaluated clinically and/ or radiologically.…”

Section: -2508/ C Audt 2023•http://wwwaudtorgmentioning

confidence: 99%

Sentinel Lymph Node Identification Using Contrast Lymphosonography: A Systematic Review

Machado¹,

Liu²,

Forsberg³

2023

Advanced Ultrasound in Diagnosis and Therapy

View full text Add to dashboard Cite

The sentinel lymph node (SLN) concept hypothesizes that metastatic cancer cells will spread through the lymphatic system to the SLN being the first one in the lymphatic chain to receive the metastatic cells, indicating that if the SLN is free of cancer cells the rest of the lymphatic chain is also without metastatic disease. Diagnostic ultrasound imaging (US) has been used to evaluate lymph nodes (LN) to determine level of suspicion and to guide LN biopsies. However, conventional US cannot be used for lymphatic mapping, which requires administration of a tracer. This has been changed with the use of contrast-enhanced US (CEUS) to detect lymphatic channels and SLNs after subcutaneous injections of microbubble-based US contrast agents (UCAs). The aim of this review is to examine the clinical evidence on the role of subcutaneous injection of UCA, known as lymphosonography, to be used as preoperative identification of SLNs in patients with breast and other cancers.

show abstract

Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast‐enhanced ultrasound: An updated meta‐analysis

Cited by 10 publications

References 20 publications

Diagnostic Significance of 3D Automated Breast Volume Scanner in a Combination with Contrast-Enhanced Ultrasound for Breast Cancer

Diagnostic Significance of 3D Automated Breast Volume Scanner in a Combination with Contrast-Enhanced Ultrasound for Breast Cancer

Sentinel Lymph Node in Breast Cancer: An Innovative Techniques

Sentinel Lymph Node Identification Using Contrast Lymphosonography: A Systematic Review

Contact Info

Product

Resources

About